-
-
Call more information
660-596-2224 -
An investigational agent that blocks a key headache-related receptor significantly reduces the number of mean monthly migraine days, new phase 2 data show. Findings showed that after 52 weeks, 18.5% of patients with migraine were free of these attacks, Uwe Reuter, PD Dr, MBA, Department of Neurology, and headache clinic director, Charité Universitätsmedizin, Berlin, Germany, […]
Read MoreThe Current State of the Opioid Abuse Epidemic Two Princeton economists startled Americans recently when they reported that between 1999 and 2013, white middle-aged men and women in the United States, especially those with a high school education, were dying at an increasing rate from prescription and illegal drug overdose, alcohol and liver-related disease, and […]
Read MoreAmid heightened efforts to try to prevent pain and surgical patients from developing long-term opioid use or misuse, one research team has come up with a handy alternative to time-consuming screening tools for identifying patients at risk, while other researchers report on key risk factors linked to long-term use. In the first of the studies […]
Read MoreEarly results from a European trial of colonoscopy has two important lessons for the practice, which has been widely embraced in the United States. The lessons from the NordICC study, preliminary results on practical points of performing colonoscopy, were published online May 23 in JAMA Internal Medicine. (However, data on the primary end points of colorectal cancer mortality and […]
Read MoreNeuraxial anesthesia (NA) appears to be associated with improved overall survival (OS) in patients undergoing surgery for tumor resection, particularly in those with colorectal cancer. According to a recent meta-analysis published in Oncotarget (2016;7:15262-15273), the authors identified a correlation between the use of NA and reduced risk for cancer recurrence. The authors found significantly improved OS […]
Read More